EdgarLookup

Enliven Therapeutics, Inc. — SC 13G/A Filings

22 SC 13G/A filings on record

This page lists all SC 13G/A filings submitted to the SEC by Enliven Therapeutics, Inc. (ELVN), sorted by most recent first. Each row links to the full filing on EdgarLookup. Enliven Therapeutics, Inc. has filed 22 SC 13G/A documents with the SEC since 2016. To view all SEC filings by Enliven Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-Q 144 144/A 3 4 4/A 424B3 424B4 424B5 425 8-A12B 8-K 8-K/A ARS CERT CORRESP D DEF 14A DEFA14A DEFM14A DRS DRS/A DRSLTR EFFECT PRE 14A PREM14A S-1 S-1/A S-3 S-3ASR S-3MEF S-4 S-4/A S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
SC 13G/A SC 13G/A 0001104659-24-119324 Nov 14, 2024
SC 13G/A SC 13G/A 0001104659-24-119290 Nov 14, 2024
SC 13G/A SC 13G/A 0001104659-24-118989 Nov 14, 2024
SC 13G/A SC 13G/A 0001104659-24-118930 Nov 14, 2024
SC 13G/A 0001493152-24-045847 Nov 14, 2024
SC 13G/A SC 13G/A 0001104659-24-024232 Feb 14, 2024
SC 13G/A SC 13G/A 0001104659-24-023957 Feb 14, 2024
SC 13G/A 0001493152-24-006623 Feb 14, 2024
SC 13G/A SC 13G/A 0001104659-24-023529 Feb 14, 2024
SC 13G/A 0000315066-24-001160 Feb 9, 2024
SC 13G/A 0001616824-24-000030 Feb 7, 2024
SC 13G/A 0001493152-23-006259 Feb 28, 2023
SC 13G/A SC 13G/A 0001104659-23-026062 Feb 27, 2023
SC 13G/A 0001493152-23-005642 Feb 21, 2023
SC 13G/A SC 13G/A 0001104659-23-021822 Feb 14, 2023
SC 13G/A 0001493152-23-004858 Feb 14, 2023
SC 13G/A NONE 0001567619-23-002081 Feb 8, 2023
SC 13G/A NONE 0001567619-22-008872 Apr 25, 2022
SC 13G/A 0000315066-22-001470 Mar 10, 2022
SC 13G/A 0000315066-22-001012 Feb 9, 2022
SC 13G/A 0000315066-21-001724 Sep 10, 2021
SC 13G/A 0000315066-21-001072 Feb 8, 2021